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p21, a p53-induced gene product that blocks cell cycle
progression at the G1 phase, interacts with both cyclin-
dependent kinases and proliferating cell nuclear antigen
(PCNA). PCNA functions as a processivity factor for DNA
polymerases δ and ε and is required for both DNA replica-
tion and nucleotide excision repair. Previous studies have
shown that p21 inhibits simian virus 40 (SV40) DNA repli-
cation in HeLa cell extracts by interacting with PCNA. In
this report we show that p21 blocks nucleotide excision
repair of DNA that has been damaged by either ultraviolet
radiation or alkylating agents, and that this inhibition can
be reversed following addition of PCNA. We have deter-
mined that p21 is more effective in blocking DNA resynthe-
sis than in inhibiting the excision step.
We further show that a peptide derived from the car-
boxyl terminus of p21, which specifically interacts with
PCNA, inhibits polymerase δ-catalyzed elongation of
DNA chains almost stoichiometrically relative to the
concentration of PCNA. When added at higher levels,
this peptide also blocks both SV40 DNA replication and
nucleotide excision repair in HeLa cell extracts. These
results indicate that p21 interferes with the function of
PCNA in both in vitro DNA replication and nucleotide
excision repair.
In response to DNA damage, higher eukaryotic cells elevate
the level of the tumor suppressor protein p53 (Maltzman and
Czyzyk, 1984; Kastan et al., 1991; Fritsche et al., 1993; Hall et
al., 1993). This protein functions as a sequence-specific tran-
scription factor that activates the synthesis of a number of
proteins that act as cell cycle regulators. One such protein, p21
(also known as Cip1, WAF1, and Sdi1), binds to cyclin-depend-
ent kinases (CDKs)1 and inhibits their activity resulting in cell
cycle arrest at the G1 phase, presumably to allow for the repair
of damaged DNA (El-Deiry et al., 1993; Harper et al., 1993; Gu
et al., 1993;Xiong et al., 1993; Noda et al., 1994). However, p53
is not the only transcriptional inducer of p21. It has recently
been shown by several laboratories that p21 expression can be
regulated independently of p53 during several situations in-
cluding normal tissue development and cellular differentiation
(Halevy et al., 1995; Parker et al., 1995; Macleod et al., 1995).
Thus, p21 appears to function as a general growth inhibitor in
response to DNA damage and cellular differentiation.
Subsequent studies have shown that, in addition to its abil-
ity to bind to CDKs, p21 also directly interacts with proliferat-
ing cell nuclear antigen (PCNA) (Flores-Rozas et al., 1994;
Waga et al., 1994). Chen et al. (1995) and Luo et al. (1995) have
shown that these two distinct inhibitory activities of p21 reside
in different domains of the protein. The NH2-terminal domain
of p21 contains the CDK inhibitory activity, while the COOH-
terminal domain contains the PCNA binding and the DNA
synthesis inhibitory activities. Luo et al. (1995) have shown
that when separately expressed in R-1B/L17 cells, each of these
domains is able to block DNA synthesis. This finding suggests
that p21 may function to block entry into S phase by two
different mechanisms: inactivating CDKs or neutralizing the
function of PCNA.
PCNA acts as a processivity factor for both DNA polymerases
δ and ε (pol δ and ε), and is required for DNA replication (for
reviews, see Chalberg and Kelly (1989), Stillman (1989), and
Hurwitz et al. (1990)). In the presence of a primer-binding
protein, replication factor C (RF-C; also known as activator 1,
A1; for reviews see Tsurimoto et al. (1990) and Hurwitz et al.
(1990)), PCNA is loaded onto the DNA primer junction allowing
the binding of pol δ or ε, which can then catalyze the elongation
of DNA chains (Lee and Hurwitz, 1990; Burgers, 1991). These
three proteins (PCNA, RF-C, and pol δ) constitute the pol δ
holoenzyme, which is essential for the replication of simian
virus 40 (SV40) DNA in vitro. p21 has been shown to inhibit
both in vitro SV40 DNA replication and the elongation of
primed DNA templates catalyzed by the pol δ holoenzyme
(Flores-Rozas et al., 1994; Waga et al., 1994). In each system,
the inhibition by p21 was found to be reversed by the addition
of excess PCNA. Quantitative analysis of the binding of p21 to
PCNA indicates that 1 mol of p21 binds to each monomer of
PCNA. The active form of PCNA in DNA replication has been
shown to be a trimer (Krishna et al., 1994). The inhibition of
the processive action of the pol δ holoenzyme by p21 has been
shown to depend on both the molar ratio between p21 and
PCNA and on the length of DNA replicated. Higher ratios of
p21 to PCNA were found to be more inhibitory and the replica-
tion of longer chains was more sensitive to p21 than the exten-
sion of DNA chains over short lengths (Flores-Rozas et al., 1994).
* This work was supported in part by National Institutes of Health
Grants GM38559 (to J. H.), GM32833 (to A. S.), and CA52461 (to R. L.)
and a grant from the Human Frontier Science Program (to A. S.). The
costs of publication of this article were defrayed in part by the payment
of page charges. This article must therefore be hereby marked "adver-
tisement" in accordance with 18 U.S.C. Section 1734 solely to indicate
this fact.
§ These authors contributed equally to this work.
** Professor of the American Cancer Society. To whom correspond-
ence should be addressed: Graduate Program in Molecular Biology,
Memorial Sloan-Kettering Cancer Center, 1275 York Ave., Box 97, New
York, NY 10021.
1 The abbreviations used are: CDK, cyclin-dependent kinase; AAAF,
N-acetoxy-2-acetylaminofluorine; PCNA, proliferating cell nuclear an-
tigen; HSSB, human single-stranded DNA-binding protein; SV40, sim-
ian virus 40; T antigen, simian virus 40 large tumor antigen; DTT,
dithiothreitol; PMSF, phenylmethanesulfonyl fluoride; PAGE, poly-
acrylamide gel electrophoresis; pol, polymerase; CFE, cell-free extracts;
RF-C, replication factor C.
22008
This is an Open Access article under the CC BY license.
p21 Inhibits Nucleotide Excision Repair 22009
In addition to its role in replication, PCNA is also essential
for DNA nucleotide excision repair (Shivji et al., 1992; Nichols
and Sancar, 1992). Nucleotide excision occurs through the in-
troduction of nicks 3-5 nucleotides 3' and 22-24 nucleotides 5'
to the site of damage, resulting in the removal of fragments
25-29 nucleotides in length (Huang et al., 1992; Svoboda et al.,
1993). This gap is then filled in by pol δ or \?\ with the undam-
aged strand acting as the template (Zeng et al., 1994;
Aboussekhra et al., 1995). PCNA is thought to act in conjunc-
tion with the DNA polymerase during nucleotide excision re-
pair, undertaking a role similar to that observed in replication.
We have investigated the effect of p21 on PCNA-dependent
DNA nucleotide excision repair in vitro. In this report, we
present evidence that both the p21 protein and a peptide de-
rived from the carboxyl end of p21 that binds PCNA specifically
inhibit the repair of DNA that has been damaged by either
alkylating agents or by ultraviolet (UV) radiation treatment.
We further determined that this inhibition results from the
ability of p21 to block the DNA resynthesis reaction following
the excision of the damaged nucleotides. These findings are
contradictory to previous reports by Li et al. (1994) and Shivji
et al. (1994), who found that high levels of p21, which blocked
DNA replication, did not affect nucleotide excision repair.
MATERIALS AND METHODS
Cell-free Extracts, Proteins, and Peptides — HeLa cell cytosolic and
WI-L2 whole cell extracts, used in Figs. 1-6, were prepared as de-
scribed previously by Wobbe et al. (1985) and Manley et al. (1980),
respectively. HeLa S3 cells were obtained from the stock of Lineberger
Comprehensive Cancer Center (University of North Carolina) and cell-
free extracts (CFE) used in Figs. 7-9, were prepared by the method of
Manley (Manley et al., 1980). CFE were stored at 15 mg/ml in 25 mM
Hepes-KOH, pH 7.9, 0.1 M KC1, 12 mM MgCl2, 0.5 mM EDTA, 2 mM DTT,
and 16% glycerol (v/v); CFE stored in this manner were active for at
least three cycles of thawing and freezing at -80 °C.
PCNA, RF-C, HSSB, and pol δ were prepared as described previously
(Kenny et al., 1990; Lee et al., 1991a). In all experiments, where indi-
cated, the concentration of PCNA refers to the monomer form. The p21
peptide (GRKRRQTSMTDFYHSKRRLIFS) derived from the COOH
terminus of p21 spans amino acids 139-160 and was synthesized in the
Microchemistry Laboratory of Sloan-Kettering Cancer Institute and
stored either as the solid or dissolved in 10 mM Tris-HCl, pH 8.0, 1 mM
EDTA, and 0.1 M NaCl.
Escherichia coli UC6444 was transformed with plasmid pHIT5 in
order to express the Nth protein (both were kindly provided by R.
Cunningham, State University of New York, Albany), which was then
isolated based on a procedure provided by R. Cunningham (Cunning-
ham and Weiss, 1985).
Preparation of p21 — The human histidine-tagged p21 (the construct
was kindly provided by Dr. J. Massague, Sloan-Kettering Cancer Insti-
tute) was overproduced under the control of T7 RNA polymerase in E.
coli (BL21-DE3). Freshly transformed bacteria were grown overnight in
Luria broth containing 0.4% glucose and 0.5 mg/ml ampicillin at 37 °C.
The overnight culture was diluted 1:100 with the same media (1 liter)
and grown at 37 °C for 2.5 h to an A600 of 0.5. Isopropyl-1-thio^-D-
galactopyranoside (1 mM) was added, and the mixture was incubated for
an additional 3.5 h. The cells were pelleted and lysed in 40 ml of buffer
A (50 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 5 mM imidazole, 1 mg/ml
lysozyme, 2 mM PMSF, 4 fig/ml antipain, and 2 µg/ml leupeptin) for 30
min at 0 °C. After sonication (six repetitive 20-s treatments) and cen-
trifugation at 39,000 x g for 20 min, the pellet containing more than
90% of the expressed p21, was washed once with 20 ml of buffer A and
then resuspended in 20 ml of buffer B (50 mM Tris-HCl, pH 8.0, 20 mM
DTT, 6 M urea, and 1 mM PMSF). After a brief sonication (three repet-
itive 15-s treatments) and centrifugation at 20,000 X g for 15 min, the
supernatant (76 mg of protein, 19 ml) was used for the purification of
p21. The 6 M urea extract was diluted 3-fold with buffer C (50 mM
Tris-HCl, pH 7.8, 5 mM EDTA, 10% glycerol, 0.1% Triton X-100, 1 mM
PMSF, 0.4 fig/ml antipain, and 0.2 µg/ml leupeptin), and chromato-
graphed on a DEAE-Sepharose column (2.5 X 4 cm, 20 ml), equilibrated
with 200 ml of buffer D (buffer C + 2 M urea + 5 mM DTT). The column
was washed with 50 ml of buffer D. The flow-through and wash frac-
tions were pooled (44 mg of protein, 110 ml) and dialyzed against 2
liters of buffer E (25 mM Tris-HCl, pH 7.5, 1 mM EDTA, 0.01% Nonidet
P-40, 10% glycerol, 1 mM DTT, 0.1 mM PMSF, 0.2 µg/ml antipain, and
0.1 µg/ml leupeptin) containing 0.5 M NaCl for 12 h at 4 °C. The
resulting fraction was completely soluble and was diluted 10-fold prior
to chromatography through an S-Sepharose column (1.5 X 4 cm, 8 ml),
equilibrated with 80 ml of buffer E plus 0.05 M NaCl. The protein was
eluted with an 80-ml linear gradient of 0.05 to 1 M NaCl in the same
buffer; 5.5 mg of p21 eluted from the column at 0.25 M NaCl. The peak
fraction of p21 eluting from the S-Sepharose column (fraction 12, 0.96
mg of protein/ml; see text for details) was used in this study.
The p21 protein that bound to the DEAE-Sepharose column was
eluted with buffer D containing 0.5 M NaCl, yielding 35 mg of protein.
This fraction could be solubilized and further purified using the proce-
dure described above.
Preparation of Repair Substrates — UV-damaged DNA substrate free
of pyrimidine hydrates (used in Figs. 1-3 and 5) was prepared as
described by Wood et al. (1988) by irradiating pUC18 plasmid DNA with
UV light, followed by treatment with the E. coli Nth protein and
purification through a 5-25% sucrose gradient. pVL1393 (9.6 kilobase
pairs, Invitrogen) was used as a control plasmid.
The preparation of N-acetoxy-2-acetylaminofluorine (AAAF)-treated
pBSIIKS plasmid DNA (used in experiments described in Fig. 6) was as
described previously (Legerski et al., 1977; Landegent et al., 1984).
pGEX2T was used as a control plasmid.
The DNA substrate used to assay both damage-specific DNA synthe-
sis and excision (described in Figs. 7-9) was a double-stranded 140-mer
containing a cholesterol "lesion" in place of a normal base at position 70
of one strand. The oligomers (Matsunaga et al., 1995) used to prepare
this substrate were purchased from Operon Technologies, Inc. or Mid-
land Certified Reagent Co., T4 polynucleotide kinase and T4 DNA
ligase were purchased from New England Biolabs, Inc., and [y-32P]ATP
was from ICN. The substrate used to measure repair synthesis was
prepared by mixing equimolar amounts of the two complementary
140-mers, one containing the cholesterol lesion, in a solution containing
20 mM Tris-HCl, pH 7.5, 50 mM NaCl, and 2 mM MgCl2; after heating at
90 °C for 5 min, the DNA was annealed by slow cooling to 25 °C over a
period of several hours. The substrate was stored at -20 °C in anneal-
ing buffer and diluted prior to use in a buffer containing 1 mM Tris-HCl,
pH 7.4, 1 mM NaCl, and 0.1 mM EDTA. The substrate used in the
excision assay contains a 32P-radiolabel 5' to the lesion and was pre-
pared as described previously (Matsunaga et al., 1995). This substrate
was stored and diluted as described above for the assay of repair
synthesis.
Repair Assays — Repair assays with the UV-damaged DNA (described
in Figs. 1-3 and 5) were carried out as described previously (Wood et al.,
1988; Sibghat-Ullah et al., 1989). Reaction mixtures (40 ) contained
40 mM creatine phosphate, pH 7.7, 50 µg/ml creatine kinase, 7 mM
MgCl2, 0.5 mM DTT, 2 mM ATP, 8 µM [α-32P]dCTP (~29,000 cpm/pmol),
20 µM other dNTPs, 14.4 µg of bovine serum albumin, 70 mM KC1, 0.4
mM EDTA, 3.4% glycerol, 0.3 µg each of the UV-damaged and control
plasmid DNA and HeLa cytosolic extracts as indicated. After incubation
at 37 °C, as indicated, the mixture was treated with proteinase K (0.1
mg/ml) in the presence of 0.5% SDS, 5 mM EDTA, and 40 µg of glycogen
at 37 °C for 30 min. DNA was recovered following phenol/chloroform
extraction and ethanol precipitation and then linearized by BamHI
digestion at 37 °C for 60 min. The two plasmids present in the repair
reactions were separated by 0.8% agarose gel electrophoresis and visu-
alized by ethidium bromide staining. Following autoradiography, the
radioactive DNA band was excised and quantitated by liquid scintilla-
tion counting.
Repair assays with AAAF-treated DNA (see Fig. 6) were carried out
as described previously (Wood et al., 1988). Reaction mixtures (50 µl)
contained 192 µg of WI-L2 whole cell extract protein, 0.25 µg each of
damaged and undamaged DNAs, and other components as described
(Wood et al., 1988). Histidine-tagged p21 (a gift of Dr. J. W. Harper; see
Harper et al. (1993)) was added to the reaction mixture in the absence
of DNA, and the mixture was incubated on ice for 30 min. After the
addition of DNA, the reaction mixture was incubated at 30 °C for
another 3 h.
In the repair assays described in Figs. 7-9, HeLa CFE (50 µg, 2
mg/ml) was mixed with substrate DNA (2 pmol) in reactions (25 µl)
containing 35 mM Hepes (pH 7.9), 10 mM Tris-HCl (pH 7.5), 60 mM KC1,
40 mM NaCl, 5.6 mM MgCl2, 0.4 mM EDTA, 0.8 mM DTT, 2 mM ATP,
3.2% glycerol, 0.2 mg/ml bovine serum albumin, 200 µM each of dCTP,
dGTP, and dTTP, 8 µM dATP, and 4 µCi of [α-32P]dATP (DuPont NEN)
and incubated at 30 °C for 60 min. After the repair reaction, 32P-
radiolabeled 20-mer was added to each reaction as an internal control to
monitor the recovery of substrate DNA. The mixture was deproteinized
with proteinase K (0.2 mg/ml) followed by phenol, phenol:chloroform,
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FIG. 1. Influence of both time and
the concentration of HeLa extracts
on the repair of UV-damaged DNA. A,
reaction mixtures contained both UV-
damaged and undamaged DNA and HeLa
extracts as indicated. After incubation at
37 °C for times as indicated, the two plas-
mids were purified, linearized, and sepa-
rated by agarose gel electrophoresis. The
gel stained with ethidium bromide is
shown at the top, and the autoradiogram
is shown at the bottom. B, quantitation of
[32P]dCMP incorporated into each plas-
mid is shown. Top, 50 µg of extract pro-
tein was used. Bottom, reaction was incu-
bated for 60 min.
and ether extractions, and the DNA was precipitated with ethanol in
the presence of 40 µg of oyster glycogen. Recovered DNA was sequen-
tially digested with PvuII and HinPI (New England Biolabs, Inc.),
deproteinized, and precipitated. DNA was resuspended in formamide/
dye mixture and resolved on a 12% denaturing polyacrylamide gel.
Following autoradiography, the level of damage-specific repair synthe-
sis was determined by scanning the autoradiographs using a Molecular
Dynamics Computing Densitometer Series 300 instrument. Damage-
specific repair synthesis was quantitated by determining the amount of
labeled nucleotide incorporated into the 28-mer generated after PvuII/
HinPI digestion. Nonspecific nicking and resynthesis of the undamaged
strand was not observed (a labeled 30-mer would be generated as a
product formed by the asymmetric PvuII/HinPI restriction pattern).
The amount of repair synthesis was normalized for DNA recovery by
quantitating the amount of 20-mer added as an internal control. When
the influence of p21 protein or the p21 carboxyl-terminal peptide on
repair synthesis was examined, reactions containing the inhibitors
(diluted with a solution containing 50 mM Tris-HCl, pH 7.5, 0.2 M NaCl,
and 1 mM EDTA) were preincubated for 15 min at 30 °C with HeLa CFE
(50 µg). This was followed by the addition of the other components, and
the DNA was processed as described for the basic repair synthesis
reaction.
During experiments in which the inhibitory effect of p21 was re-
versed by PCNA, p21 was incubated with the indicated amounts of
PCNA at 30 °C for 15 min and then HeLa CFE was added to a final
concentration of 2 mg/ml. After a second 15-min incubation at 30 °C,
substrate DNA, and other reaction components (as above, except that
reactions contained 78 mM NaCl) were added to a final volume of 25 µl
and, following a 60-min incubation at 30 °C, the DNA was processed as
described for the basic repair synthesis reaction.
Excision Assay — The reaction conditions used were similar to those
described for the repair synthesis assay, except that 3-5 fmol of sub-
strate DNA (approximately 50,000 cpm) was used for each 25-µl reac-
tion. pBR322 (150 ng) was included in each reaction, as well as 20 µM
nucleotides followed by a 45-min incubation at 30 °C. Preincubation
with p21 or the peptide was as described. Since the excision assay did
not require restriction digestion, DNA recovered after the initial depro-
teinization and precipitation steps was resuspended in the formamide/
dye mixture and resolved on a 12% denaturing polyacrylamide gel.
Quantitation of excision (oligomers in the 23-30-nucleotide range) rel-
ative to the recovery of the added substrate was determined by either
scanning autoradiographs with a Molecular Dynamics Computing Den-
sitometer or by scanning dried gels with an AMBIS Systems Scanner.
DNA Replication Assays — SV40 DNA replication and the elongation
of singly primed M13 DNA were carried out as described previously
(Wobbe et al., 1985; Flores-Rozas et al., 1994).
RESULTS
Influence of p21 on Repair of UV-damaged DNA — UV dam-
age to DNA leads to the formation of pyrimidine dimers and
6-4 photoproducts that are primarily repaired by the nucleo-
tide excision pathway in mammalian cells (for reviews, see
Sancar (1994) and Friedberg et al. (1995)). During nucleotide
excision repair, the damage is removed by dual incisions in the
form of 27-29-nucleotide-long oligomers (Huang et al., 1992)
and the resulting gap is filled in by DNA polymerases. PCNA
has been shown to play an essential role in the repair of
UV-damaged DNA (Shivji et al., 1992; Nichols and Sancar,
1992). Repair can be quantified by measuring either the level of
the excised fragment (excision assay; Huang et al., 1992) or the
level of incorporation of radiolabeled nucleotides (repair syn-
thesis assay; Wood et al., 1988; Sibghat-Ullah et al., 1989). In
order to assess the influence of p21 on the PCNA-dependent
repair reaction, we initially examined the efficiency of the
repair synthesis reaction as a function of both time and the
concentration of HeLa extract added for the repair of UV-
damaged DNA. As shown in Fig. 1, in the presence of 1.25
mg/ml HeLa extract, the rate of the repair of UV-damaged
DNA was linear up to 60 min and continued to increase for at
least 2 h.
The influence of p21 on the repair of UV-damaged DNA was
examined (Fig. 2). For this purpose, the bacterial-expressed
p21 protein was chromatographed through an S-Sepharose
column and eluted using a salt gradient (see "Materials and
Methods"). The elution profile of p21, measured by SDS-PAGE
analysis (Fig. 2, panel A), and the inhibition of repair activity
by aliquots of the eluted fractions (Fig. 2, panel B) were com-
pared. These results were quantitated as shown in Fig. 2 (panel
C). The peak of p21 eluted in fractions 12 and 14, coincident
with the peak of inhibition of the repair reaction.
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FIG. 2. p21 inhibits repair of UV-damaged DNA.A, SDS-PAGE analysis of the fractions isolated after S-Sepharose chromatography of p21.
The p21 protein bound to the S-Sepharose column was eluted with a linear salt gradient as described under "Materials and Methods." The
S-Sepharose eluted fractions (3 µ1) were subjected to SDS-PAGE and stained with 0.1% Coomassie Brilliant Blue. The numbers at the top of the
gel indicate the fractions analyzed. The position of the p21 protein is indicated. B, effect of p21 fractions eluted from the S-Sepharose column on
the repair of UV-damaged DNA. Reactions contained none (lane 1) or 0.75 µl of the S-Sepharose fractions (lanes 2-8, as indicated), HeLa extract
(1.26 mg of protein/ml), and other components as described under "Materials and Methods." After incubation at 37 °C for 30 min, reactions were
stopped and analyzed as described under "Materials and Methods." Both the ethidium bromide staining and autoradiogram of the gel are shown.
C, quantitation and comparison of the concentration of p21 in the various reactions and the inhibition of repair indicated as a percentage. In the
absence of p21, 0.5 pmol of [32P]dCMP was incorporated into the UV-damaged plasmid (representing 100% activity).
If the p21-mediated inhibition is due to its direct interaction
with PCNA, addition of excess PCNA to the repair reaction
should overcome this inhibition. An example of such an exper-
iment is shown in Fig. 3A. In the presence of 0.42 µM p21, the
repair reaction was inhibited 65% (Fig. 3A, lane 2), while at
0.84 µM p21, the reaction was reduced by 90% (lane 6). Addition
of 0.17 µM PCNA (in its monomer form) to reactions containing
0.42 µM p21 almost completely reversed the inhibition (lane 3).
In the presence of the higher level of p21 (0.84 µM), inhibition
of repair was only partially overcome by addition of PCNA even
at PCNA concentrations approaching 1 µM. The addition of
PCNA in the absence of p21 did not significantly affect the
repair reaction (Fig. 3A, lanes 10—12). These results indicate
that p21 inhibits the repair of UV-damaged DNA and that this
effect can be overcome following the addition of excess PCNA.
However, the extent of the reversal depends on the p21 con-
centration used.
A PCNA-interacting Peptide of p21 Inhibits DNA Replication
and the Repair of UV-damaged ZWA—p21 has been shown to
contain two distinct inhibitory domains. The NH2-terminal
region binds to and inhibits various CDKs, whereas the car-
boxyl domain binds to PCNA (Chen et al., 1995; Luo et al.,
1995). These findings explain why p21 has been found com-
plexed with CDK, cyclin, and PCNA (Xiong et al., 1992). In vitro
studies have shown that addition of CDK/cyclin A did not alter
the inhibitory action of p21 in the PCNA-dependent, pol δ-cat-
alyzed elongation of primed DNA templates. Experiments car-
ried out with the cloned NH2-terminal domain of p21 (codon
1-75), which inhibits CDKs, and the carboxyl-terminal domain
of p21 (codons 76-164), which inhibits DNA synthesis, sub-
stantiate the conclusion that each domain can act independ-
ently (Luo et al., 1995).
More recently, Warbrick et al. (1995) have shown that a
peptide derived from the carboxyl domain of p21 interacts with
PCNA and inhibits SV40 DNA replication catalyzed by crude
cytosolic extracts. We have confirmed these observations using
a peptide of 22 amino acid spanning codons 139-160 of p21. As
shown, this highly basic peptide markedly inhibited the pol
δ-holoenzyme system at concentrations even lower than those
observed with p21 (Fig. 4A, see Table I). In the presence of 0.17
µM PCNA (monomer), 0.17 µM peptide markedly inhibited the
elongation of singly primed M13 DNA template (lane 5). This
inhibition was completely reversed by the addition of excess
PCNA (0.85 µM, lane 7). In contrast to the near stoichiometric
action of the peptide with the purified system, inhibition of the
SV40 replication reaction with crude extracts required sub-
stantially more peptide and the extent of inhibition depended
on the concentration of crude HeLa cytosolic extract added. In
the presence of 2, 5, and 10 mg of extract protein/ml, 50%
inhibition of SV40 replication was observed with 25, 47, and 86
µM peptide, respectively (Fig. 4B). These levels were substan-
tially higher than the level of intact p21 required to inhibit
SV40 replication in crude extracts (see Table I for a compari-
son). The reasons for this discrepancy are unclear. The possi-
bility that the peptide was degraded by proteolysis in crude
extracts was addressed. However, the addition of protease in-
hibitors did not decrease the amount of peptide needed to
inhibit replication. Similar observations with crude extracts
were made with the carboxyl terminus of p21 (codons 76-164).2
The 22-amino acid peptide derived from the carboxyl domain
of p21 inhibited the repair of UV-damaged DNA by HeLa
extracts in a manner analogous to that observed with the SV40
DNA replication system (Fig. 5A). In the presence of 0.63 and
1.26 mg of extract protein/ml, the repair reaction was inhibited
50% by 7.7 and 29 µM of the peptide, respectively, levels
slightly higher than those required to inhibit the replication of
SV40 DNA. Nonspecific peptides, C1 and C2 (described in the
2 Y. Luo, J. Hurwitz, and J. Massague, unpublished results.
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FIG. 3. PCNA addition reversed the inhibitory effects of p21 on
the repair of UV-damaged DNA. A, all reactions contained HeLa
extracts (1.25 mg of protein/ml) and other components as described
under "Materials and Methods." The addition of p21 was as follows:
none (lanes 1 and 10-12), 0.42 µM (lanes 2 - 5), or 0.84 µM (lanes 6-9). In
experiments in which the effects of the addition of exogenous PCNA
were examined, the amount of PCNA (as a monomer) added was 0.17
µM (lanes 3, 7, and 10), 0.54 µM (lanes 4, 8, and 11), or 1.08 µM (lanes 5,
9, and 12). After incubation at 37 °C for 30 min, reactions were stopped
and analyzed as described under "Materials and Methods." Both the
ethidium bromide staining and autoradiogram of the gel are shown. B,
quantitation of the experiment shown in A. In the absence of p21, 0.5
pmol of [32P]dCMP was incorporated into the UV-damaged plasmid
(representing 100% activity).
legend to Fig. 5A), at comparable levels had no effect on the
repair reaction. These observations indicate that the PCNA-
interacting region of p21 alone is capable of inhibiting the
repair reaction in the absence of the CDK-inhibiting domain,
albeit at higher levels. At the high levels of peptide used, no
attempts was made to reverse the inhibition with additional
PCNA.
The Repair of DNA Damaged by Alkylating Agents Is Inhib-
ited by p21 — Since the repair of UV-damaged DNA is inhibited
by p21, we determined whether this was true of DNA damaged
by other agents. For this purpose, DNA alkylated by exposure
to AAAF, which leads to guanine-substituted adducts was ex-
amined (Fig. 6A). In these experiments, WI-L2 whole cell ex-
tracts were used as the source of repair factors. As shown, at
relatively high levels of p21 (between 0.38 and 0.76 µM) the
repair of alkylated DNA was inhibited (quantitation of the
FIG. 4. The influence of the p21 carboxyl-terminal peptide on
the elongation of primed DNA templates and SV40 DNA repli-
cation. A, the p21 carboxyl-terminal peptide inhibits elongation of
labeled singly primed DNA by the pol δ holoenzyme. Reaction mixtures
(10 µl) contained 30 mM Tris-HCl, pH 7.8, 2 mM DTT, 1.5 µg of bovine
serum albumin, 33.3 µM dNTPs, 2 mM ATP, 7 mM MgCl2, 5.1 fmol of
singly primed M13 DNA (2600 cpm/fmol), 0.25 µg of HSSB, 0.075 unit
of RF-C, 0.05 unit of pol δ, and PCNA and p21 carboxyl-terminal
peptide in amounts indicated. Reaction mixtures lacking RF-C and pol
δ were incubated for 5 min at 37 °C and cooled to 0 °C, and then RF-C
and pol δ were added. After 20 min at 37 °C, reaction mixtures were
adjusted to 10 mM EDTA, loading dye containing SDS was added, and
the mixtures were subjected to alkaline agarose gel (1.5%) electrophore-
sis, dried, and autoradiographed. B, the p21 carboxyl-terminal peptide
inhibits SV40 DNA replication by crude extracts of HeLa cells. Repli-
cation of SV40 DNA by crude extracts was carried out in reaction
mixtures (10 µ1) containing 75 ng of pSV01ΔEP, 0.32 µg of SV40 T
antigen, 70 ng of HSSB, crude extract from HeLa cells and the p21
carboxyl-terminal peptide as indicated, and other reagents as described
previously (Wobbe et al., 1985). Reactions were incubated for 60 min at
37 °C, and the amount of acid-insoluble radioactivity formed (using
[α-32P]dCTP) was measured. In the absence of p21 peptide, 9.22, 7.74,
and 3.29 pmol of dCMP were incorporated with 10, 5, and 2 mg respectively.
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TABLE I
Summary of effects of p21 and the p21 carboxyl-terminal peptide on nucleotide excision repair and DNA replication
The data presented here summarize the effects of p21 and the p21 carboxyl-terminal peptide on both excision and resynthesis steps of nucleotide
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a (6-4), (6-4) photoproducts. Most of the repair synthesis in UV-irradiated DNA is caused by (6-4) photoproducts, not pyrimidine dimers
(Sibghat-Ullah and Sancar, 1990).
b AAAF, N-acetoxy-2-acetylaminofluorine.
c ND, not determined.
results is shown in Fig. 6B). The concentration of PCNA pres-
ent in WI-L2 extracts was determined by quantitative Western
blotting analysis using enhanced chemiluminescence and den-
sitometric analysis. In comparison to known amounts of PCNA
loaded on the same gel, it was determined that 1 µg of whole
cell extract contained approximately 1.25 ng of PCNA (data not
presented). Based on this analysis, each reaction described in
Fig. 6 contained 0.17 µM PCNA (monomer). Thus, at a ratio of
p21:PCNA of 0.4/0.17, the repair of AAAF-damaged DNA was
inhibited by 20%; when the amount of p21 was increased 2-fold,
the repair reaction was inhibited 78%.
The repair of AAAF-DNA can also be carried out by HeLa
cytosolic extracts, and this reaction was inhibited by p21 in a
manner analogous to that observed with WI-L2 whole cell
extracts (data not shown). Excess PCNA reversed the inhibi-
tion (data not presented).
Influence of p21 on Excision and Damage-specific DNA Syn-
thesis—Repair synthesis, assayed with randomly damaged
DNA, often yields a "signal" due to DNA damage but not solely
associated with repair (Biggerstaff and Wood, 1992; Reardon et
al., 1993). In order to avoid this problem, we tested the effects
of p21 on excision and repair of DNA containing a single base
lesion. Using a double-stranded 140-mer containing a choles-
terol lesion as a substrate (a schematic drawing of the sub-
strate is shown in Fig. 7A), we assayed both damage-specific
DNA synthesis and excision of the damaged region. Damage-
specific synthesis was assayed by measuring the incorporation
of 32P-labeled dAMP into a 28-mer (encompassing about 80% of
the repair patch), derived from the repair of the damaged
strand after restriction with PvuII and HinPI, within which the
cholesterol lesion is located and removed by the excision nucle-
ases. The excision assay, as described under "Materials and
Methods," measured the release of an oligonucleotide (27-mer)
from a 140-base pair duplex that contained a 32P-labeled nu-
cleotide specifically inserted within a region containing choles-
terol in lieu of a base (Matsunaga et al., 1995).
As shown in Fig. 7 (B and C), 0.27 µM of p21 inhibited
damage-specific DNA synthesis by 50%, while approximately 2
µM of p21 was required to inhibit the excision step by 50%. The
effect of the p21 carboxyl-terminal peptide on both resynthesis
and excision steps was also determined (Fig. 8). Although the
p21 peptide inhibited resynthesis 50% at 20 µM, no effect was
observed in the excision assay at 40 µM, a concentration that
almost totally inhibited the resynthesis step.
The inhibition of resynthesis by p21 was reversed by exoge-
nous PCNA addition (Fig. 9). The slight stimulation of resyn-
thesis observed at low concentrations of PCNA (Fig. 9A, lane 4)
is most likely an experimental artifact. Reversal of the inhibi-
tion of the excision step was not attempted because of the high
concentration of p21 required for 50% inhibition. It has been
previously shown with partially purified fractions that PCNA
is required for both the excision and resynthesis steps (Nichols
and Sancar, 1992). The results presented here indicate that the
resynthesis step is more sensitive to p21 than the excision step.
In keeping with these observations, recent studies with highly
purified fractions isolated from higher eukaryotes (Mu et al.,
1995) and from Saccharomyces cerevisiae (Guzder et al., 1995)
indicate that PCNA plays no role in the excision steps. It is
interesting to note that with the highly purified excinuclease
systems examined, the release of the excised oligonucleotide
was effected by denaturing conditions. This raises the possibil-
ity that the recycling of the excision process may be stimulated
by the PCNA-dependent repair synthesis observed with par-
tially purified fractions, as previously suggested (Nichols and
Sancar, 1992).
DISCUSSION
The results presented here (summarized in Table I) demon-
strate that both p21 and a peptide derived from the carboxyl
end of p21 that binds PCNA specifically inhibit the repair of
DNA damaged by either alkylating agents or UV radiation
treatment. We further determined that this inhibition is due to
the blockage of the resynthesis reaction following the excision
step. These observations, along with those reported previously,
indicate that p21 inhibits two PCNA-dependent reactions, one
leading to the repair of damaged DNA and the other leading to
the elongation of primed DNA templates by pol δ and/or pol ε
(Flores-Rozas et al., 1994; Waga et al., 1994; Li et al., 1994). At
present it is not clear whether it is pol δ and/or pol ε that
participates in nucleotide excision repair (Zeng et al., 1994;
Aboussekhra et al., 1995), and there is also some controversy
concerning which of these two polymerases participates in lag-
ging strand maturation and in leading strand synthesis during
DNA replication (Morrison et al., 1990; Burgers, 1991; Lee et
al., 1991b; Araki et al., 1992; Budd and Campbell, 1993). Al-
though it is difficult to compare the SV40 replication reaction
and the nucleotide excision repair assay carried out by crude
extracts, the results presented here indicate that there may be
a quantitative difference in the inhibitory effects of p21 in these
reactions (see Table I for a comparison). As expected from
previous observations regarding the elongation of primed tem-
plates over short lengths (10 nucleotides) and over long regions
(7 kilobases), the replication reaction is more sensitive to inhi-
bition by p21 than the repair reaction (Flores-Rozas et al.,
1994). These studies carried out using the highly purified pol 8
holoenzyme concluded that the molar ratio of p21 to PCNA (as
a monomer) required to block short length extensions was
nearly 100-fold greater than the molar ratio required for inhi-
bition of elongation over a 7-kilobase length. From the meas-
urements of PCNA present in crude extracts, a much lower
ratio of p21 to PCNA inhibited the repair reactions (a molar
ratio of p21 to PCNA of ~3, inhibited repair about 50%).
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FIG. 5. The p21 carboxyl-terminal peptide inhibits the repair
of UV-damaged DNA. A, reactions contained HeLa cytosolic extracts
at 0.63 mg of protein/ml (lanes 1—4) or 1.26 mg of protein/ml (lanes
5—12) and other components, as described under "Materials and Meth-
ods." The p21 carboxyl-terminal peptide was added at 2.4 JAM (lane 2),
9.6 µM (lanes 3 and 6), 24 µM (lanes 4 and 7), or 48 µM (lane 8). A control
peptide C1 (NLFCSEEMPSSDDC) was added at 24 µM (lane 9) or 48 µM
(lane 10). Another control peptide C2 (EPPLSQEAFADLWKK) was
added to 24 µM (lane 11) or 48 µM (lane 12). After incubation at 37 °C for
60 min, reactions were stopped and analyzed as described under "Ma-
terials and Methods." Both the ethidium bromide staining and autora-
diogram of the gel are shown. B, quantitation of the experiment shown
in A. In the absence of the p21 peptide, 0.5 and 1.14 pmol of [32P]dCMP
were incorporated into the UV-damaged plasmid with 0.63 and 1.26
mg/ml HeLa extracts, respectively (each representing 100% activity).
Since nucleotide excision repair requires relatively short-
patch synthesis by pol δ or pol ε, we anticipated that this
PCNA-dependent reaction would be as insensitive to p21 inhi-
bition as that found in the elongation over a 10-nucleotide
stretch. However, this was not the case, suggesting that the
role of PCNA in nucleotide excision repair may prove more
complex than the role played in the pol δ or pol ε holoenzyme
reaction. At present, it is not clear how PCNA participates in
the repair of damaged DNA. It is clear that RF-C is essential
for the loading of PCNA in replication reactions, and an in-
volvement of RF-C in the repair of damaged DNA has been
suggested by Aboussekhra et al. (1995). In contrast to pol δ, pol
FIG. 6. p21 inhibits repair of AAAF-treated DNA in WI-L2
whole cell extracts. A, DNA repair reactions were carried out in the
absence (lane 1) or in the presence of increasing amounts of p21 (lanes
2—6) under conditions described under "Materials and Methods." After
incubation at 30 °C for 3 h, reactions were stopped and analyzed as
described (Wood et al., 1988). Both the ethidium bromide staining and
autoradiogram of the gel are shown. B, quantitation of the results
shown in A.
ε can extend DNA chains in the absence of RF-C and PCNA
(Nishida et al., 1988; Burgers, 1991; Lee et al., 1991b). How-
ever, in the presence of salt concentrations more closely resem-
bling physiological conditions, pol ε activity becomes com-
pletely dependent on both RF-C and PCNA (Burgers, 1991; Lee
et al., 1991b). Although PCNA can be loaded onto primed DNA
templates in the absence of RF-C, such reactions required
extremely high levels of PCNA (Burgers and Yoder, 1993).
The results presented here are in contrast to the data pre-
sented by Li et al. (1994) and by Shivji et al. (1994), who have
reported that high levels of p21 had no effect on the repair of
UV damaged DNA. The levels of p21 used in their experiments
(up to 40 µg/ml, equivalent to 1.9 µM), are well within the range
that we found inhibitory. The reasons for the discrepancy are
unclear. One contributing factor that we have noticed concerns
the degree of aggregation of p21. We have observed that, with
time, the inhibitory effects of p21 in both replication and repair
decreased, and this was correlated with increased aggregation.
This was observed with both free p21 and the histidine-tagged
p21.
Li et al. (1994) have proposed that pol δ or pol ε acts to
completely fill in the 30-nucleotide stretch essential for the
repair of the excised damaged region of DNA. In their model,
they proposed that PCNA, complexed with p21, is effective in
fixing the polymerase to the primer end but PCNA needs not
act as a processivity factor since the polymerase acts over a
short region. This provocative model suggests that the p21-
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FIG. 7. p21 protein inhibits both the excision and resynthesis
steps of nucleotide excision repair. A, schematic drawing of the
substrate and relevant restriction enzyme sites used to examine exci-
sion and damage-specific DNA synthesis. B and C, effect of p21 on the
repair synthesis (B) and excision activity (C). Assay conditions were as
described under "Materials and Methods." D, the remaining activity (%)
was determined relative to control reactions that lacked p21. The ac-
tivities observed in the absence of the inhibitors represented 100%
activity. The data points indicated represent the average of two to four
experiments, and the standard error is shown. In the figure presented,
the excision activity, assayed by release of radiolabeled fragments con-
taining the damaged site, is represented by circles, whereas the repair
synthesis, assayed by the incorporation of radiolabel into the specific
restriction fragment containing the repaired region, is represented by
squares.
PCNA complex governs how the polymerase interacts with
PCNA. In contrast, our findings suggest that the formation of
the p21-PCNA complex, which requires high levels of p21,
inhibits repair of damaged DNA. The availability of purified
excision-repair systems (Mu et al., 1995; Aboussekhra et al.,
1995) should permit a better evaluation of the role of PCNA
and the effect of p21.
Chen et al. (1995) and Luo et al. (1995) have recently shown
that while the NH2-terminal domain of p21 contains the CDK
inhibitory activity, the CH2-terminal domain contains the
PCNA binding and DNA synthesis inhibitory activities. Luo et
al. (1995) have further demonstrated that each of these do-
mains (codons 1-75 as the NH2 terminus, and codons 76-164
as the carboxyl domain), when expressed in R-1B/L17 cells, was
FIG. 8. Effect of the p21 carboxyl-terminal peptide on the re-
pair synthesis (A) and excision activity (B). Assay conditions were
as described under "Materials and Methods." C, the remaining activity
(%) was determined relative to control reactions that lacked the p21
peptide. The activities observed in the absence of the inhibitors repre-
sented 100% activity. The data points indicated represent the average
of two to four experiments, and the standard error is shown. In the
figure presented, the excision activity was assayed by the release of
radiolabeled fragments containing the damaged site and is represented
by circles. The repair synthesis, assayed by the incorporation of radio-
label into the specific restriction fragment containing the repaired
region, is represented by squares.
sufficient to block DNA synthesis, although the carboxyl do-
main of p21 was less efficient. There is some controversy con-
cerning the growth-inhibitory effect of the carboxyl terminus of
p21 in vivo. Chen et al. (1995) have reported that overexpres-
sion of the NH2-terminal domain of p21 (codons 1-90), but not
the carboxyl end (codons 87-164) in human SaOs2 cells,
blocked cell growth. However, the expression of the carboxyl
end of p21 and its interaction with PCNA in transfected SaOs2
cells was not examined.
It appears that CDKs are the prime targets of p21 in blocking
entry into S phase. What is the physiological significance of
inhibition of PCNA function by p21? We postulate that there is
a quantitative difference in the level of p21 induced by p53 in
response to DNA damage. Relatively low levels of p21 are
sufficient to inhibit CDK activity but not to inhibit PCNA. As a
result, cells are arrested in G1 to repair DNA damage. How-
ever, when the level of p21 induced becomes higher, perhaps
due to severe DNA damage, it acts to inhibit PCNA function in
both DNA replication and repair. The PCNA-inhibitory func-
tion of p21 is perhaps related to p53-induced apoptosis. How-
ever, it remains to be determined whether p21 is required for
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FIG. 9. Influence of the addition of exogenous PCNA on the
repair synthesis of the 140-mer oligonucleotide substrate car-
ried out in the presence or absence of p21. Assay conditions were
as described under "Materials and Methods." A, an autoradiograph
illustrating the repair synthesis assay with HeLa CFE, p21 and PCNA.
Numbers to the left indicate the size in nucleotides of the DNA frag-
ments. The 28-mer is the fragment containing the repair patch,
whereas the 20-mer is the internal control DNA. The other radiolabeled
fragments result from nonspecific incorporation. B, quantitation of the
results shown in A. The value 100% (shown in lane 1) was obtained from
the amount of radioactivity recovered in the 28-mer.
p53-mediated apoptosis and whether DNA replication and
repair functions are impaired by p21 in cells committed to
apoptosis.
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